Drug Type Small molecule drug |
Synonyms |
Mechanism HIV envelope protein gp120 inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H18ClFN4O2S |
InChIKeyTYOUIZRAPWQCSE-UHFFFAOYSA-N |
CAS Registry1887241-45-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
HIV Infections | Preclinical | US | 01 Nov 2016 |